Cargando…

Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3

BACKGROUND: MicroRNAs are small non-coding RNAs with pivotal regulatory functions in multiple cellular processes. Their significance as molecular predictors for breast cancer was demonstrated in the past 15 years. The aim of this study was to elucidate the role of hsa-miR-3651 for predicting of loca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zellinger, Barbara, Bodenhofer, Ulrich, Engländer, Immanuela A., Kronberger, Cornelia, Grambozov, Brane, Ruznic, Elvis, Stana, Markus, Karner, Josef, Fastner, Gerd, Sotlar, Karl, Sedlmayer, Felix, Zehentmayr, Franz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885475/ https://www.ncbi.nlm.nih.gov/pubmed/34865205 http://dx.doi.org/10.1007/s12282-021-01308-y

Ejemplares similares

Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast Cancer
por: Zellinger, Barbara, et al.
Publicado: (2020)

High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC
por: Grambozov, Brane, et al.
Publicado: (2022)

Carbon Monoxide Diffusing Capacity (DL(CO)) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III
por: Stana, Markus, et al.
Publicado: (2022)

Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL(CO) Correlate with Radiation Dosimetry and Pneumonitis Rate
por: Stana, Markus, et al.
Publicado: (2023)

Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single‐center retrospective analysis
por: Grambozov, Brane, et al.
Publicado: (2021)

Hsa-miR-375 is a predictor of local control in early stage breast cancer
por: Zehentmayr, Franz, et al.
Publicado: (2016)

Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic review
por: Zehentmayr, Franz, et al.
Publicado: (2020)

Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis
por: Grambozov, Brane, et al.
Publicado: (2021)

Pulmonary function decreases moderately after accelerated high‐dose irradiation for stage III non‐small cell lung cancer
por: Grambozov, Brane, et al.
Publicado: (2019)

Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity
por: Wass, Romana, et al.
Publicado: (2022)

miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites
por: Rinnerthaler, Gabriel, et al.
Publicado: (2016)

Boost IORT in Breast Cancer: Body of Evidence
por: Sedlmayer, Felix, et al.
Publicado: (2014)

The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma
por: Lyons Rimmer, Jade, et al.
Publicado: (2020)

MicroRNA-3651 promotes the growth and invasion of hepatocellular carcinoma cells by targeting PTEN
por: Zhao, Xinyang, et al.
Publicado: (2019)

Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation
por: Zehentmayr, Franz, et al.
Publicado: (2019)

Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer
por: Rendl, Gundula, et al.
Publicado: (2014)

Intraoperative radiotherapy (IORT) as boost in breast cancer
por: Sedlmayer, Felix, et al.
Publicado: (2017)

The Role of FRMD7 in Idiopathic Infantile Nystagmus
por: Watkins, Rachel J., et al.
Publicado: (2012)

Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid)
por: Zehentmayr, Franz, et al.
Publicado: (2015)

Nonmetastatic pancreatic cancer: Improved survival with chemoradiotherapy > 40 Gy after systemic treatment
por: Bachmayer, Sebastian, et al.
Publicado: (2018)

Abnormal retinal development associated with FRMD7 mutations
por: Thomas, Mervyn G., et al.
Publicado: (2014)

Correlations of FRMD7 gene mutations with ocular oscillations
por: Huang, Lijuan, et al.
Publicado: (2022)

Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice
por: Piroth, Marc D., et al.
Publicado: (2021)

Identification of a novel FRMD7 splice variant and functional analysis of two FRMD7 transcripts during human NT2 cell differentiation
por: Li, Yingzhi, et al.
Publicado: (2011)

Analysis of the Role of FRMD5 in the Biology of Papillary Thyroid Carcinoma
por: Gaweł, Agata M., et al.
Publicado: (2021)

Novel mutations of FRMD7 in Chinese patients with congenital motor nystagmus
por: Jia, Xiuhua, et al.
Publicado: (2017)

miR-3651 Participates in the Growth Cycle of Hepatocellular Carcinoma Cells and Promotes the Malignant Metastasis via the PI3K/AKT/mTOR Signalling Pathway
por: Liu, Yawei, et al.
Publicado: (2022)

First clinical application of image-guided intraoperative electron radiation therapy with real time intraoperative dose calculation in recurrent rectal cancer: technical procedure
por: Roeder, Falk, et al.
Publicado: (2023)

A FRMD7 variant in a Japanese family causes congenital nystagmus
por: Kohmoto, Tomohiro, et al.
Publicado: (2015)

Exosomal hsa_circRNA_104484 and hsa_circRNA_104670 may serve as potential novel biomarkers and therapeutic targets for sepsis
por: Tian, Chang, et al.
Publicado: (2021)

Expression and localization of FRMD7 in human fetal brain, and a role for F-actin
por: Pu, Jiali, et al.
Publicado: (2011)

FRMD3 gene: its role in diabetic kidney disease. A narrative review
por: Buffon, Marjoriê Piuco, et al.
Publicado: (2015)

Willin/FRMD6: A Multi-Functional Neuronal Protein Associated with Alzheimer’s Disease
por: Chen, Doris, et al.
Publicado: (2021)

FRMD7 Gene Alterations in a Pakistani Family Associated with Congenital Idiopathic Nystagmus
por: Arshad, Muhammad Waqar, et al.
Publicado: (2023)

Willin/FRMD6 Mediates Mitochondrial Dysfunction Relevant to Neuronal Aβ Toxicity
por: Chen, Doris, et al.
Publicado: (2022)

Five novel mutations of the FRMD7 gene in Chinese families with X-linked infantile nystagmus
por: Li, Ningdong, et al.
Publicado: (2008)

Identification of Three Novel Mutations in the FRMD7 Gene for X-linked Idiopathic Congenital Nystagmus
por: Zhang, Xiao, et al.
Publicado: (2014)

From Single Nucleotide Polymorphism to Transcriptional Mechanism: A Model for FRMD3 in Diabetic Nephropathy
por: Martini, Sebastian, et al.
Publicado: (2013)

FRMD4A: A potential therapeutic target for the treatment of tongue squamous cell carcinoma
por: Zheng, Xianghuai, et al.
Publicado: (2016)

FRMD7 Mutations Disrupt the Interaction with GABRA2 and May Result in Infantile Nystagmus Syndrome
por: Jiang, Lei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cr5l39grs5s189tfqeu8djidis